Read more: http://www.bloglution.com/2013/08/how-to-enable-rss-auto-discovery-in.html#ixzz2ik0NTKwC

Friday, May 3, 2013

Latest Report: World Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease



GBI Research’s report: Immunoglobulin Market to 2019 provides in-depth analysis of the global immunoglobulin market. The report analyzes the markets for immunoglobulin products in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan. The revenue and annual cost of therapy are forecast for the key geographies and in seven key therapeutic segments, along with epidemiology data, until 2019. 

The seven key therapeutic segments are Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Guillain-Barré Syndrome (GBS), Myasthenia Gravis (MG), Idiopathic Thrombocytopenic Purpura (ITP), and Chronic Lymphocytic Leukemia (CLL). The report also profiles the marketed products, key pipeline products, and leading companies that could change the market landscape in the forecast period. 


The report has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. GBI Research expects the immunoglobulin market to see a slight increase in its growth rate during the 2012–2019 forecast period. It was worth $3.6 billion in 2012, having grown at a Compound Annual Growth Rate (CAGR) of 6% from 2006. Demand for immunoglobulin products continues to increase due to growing disease awareness and therapeutic usage in a wide range of therapeutic areas. Immunology and neurology are the disciplines that use the most immunoglobulins, while PI and CIDP are the top indications. 

Geographically, the US is the largest market, commanding a share of over 70% of the global market. 11 new products have been approved in the US since 2006, but as many are for PI or ITP, immunoglobulin usage in the US remains off-label for all other indications. Baxter, CSL Behring, and Grifols continue to command the top ranks in terms of revenue, and recent approvals of Subcutaneous Immunoglobulins (SCIGs) in the US and Europe will further boost market growth.

Scope

  • Annualized market data for the immunoglobulin market from 2006 to 2012 and forecast to 2019
  • Analysis of the seven key therapeutic segments: PI, CIDP, MMN, MG, CLL, GBS and ITP
  • Analysis of the immunoglobulins markets in the leading global geographies: the US, the top five European countries, and Japan
  • Market characterization of the immunoglobulin market, covering size, revenue analysis by geography, annual cost of therapy, and epidemiology
  • Key drivers and barriers that have a significant impact on the market
  • Coverage of key marketed products, approved indications, and safety and efficacy profiles
  • Coverage of the pipeline molecules in various phases of drug development
  • Competitive profiling of the leading companies: Baxter, Biotest, Bio Products Laboratory, CSL Behring, Grifols, and Octapharma
  • Key M&A activity and licensing agreements between 2012 and mid-2013 in the global immunoglobulin market
  • Overview of the immunoglobulin markets in Asia-Pacific and China, covering regulations, key players and marketed products

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/167419


Reasons to Buy

  • Align your product portfolio to the markets with high growth potential
  • Develop market-entry and market-expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
  • Develop key strategic initiatives by understanding the key focus areas of the leading companies
  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps


Latest Report:

China Natural Crude Oil And Natural Gas Mining Industry, 2013: http://www.marketresearchreports.biz/analysis/161718

China natural crude oil and natural gas mining industry, 2013 is valuable for anyone who wants to invest in the natural crude oil and natural gas mining industry, to get Chinese investments; to import into China or export from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy as China is leading the way; or to compete in the segment. The report provides the whole set of the industry data, in-depth analysis and detailed insight into the natural crude oil and natural gas mining industry, market drivers, key enterprises and their strategies, as well as technologies and investment status, risks and trends.

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog: http://chinamarketreports.blogspot.com/

No comments:

Post a Comment